Literature DB >> 2984900

Testicular carcinoma. A curable malignancy.

O Dahl.   

Abstract

The progress in the management of testicular germ cell tumours is reviewed. A marked improvement of the treatment results has been obtained in non-seminomas, especially by the use of cis-platinum based chemotherapy. At present long term survival can be expected in 85 per cent of all non-seminomas and in 95 per cent of all seminomas after adequate treatment. The natural history of the disease, symptomatology, diagnostic procedures, staging and different treatment modalities, as surgery, radiation therapy, chemotherapy and their combination, are discussed.

Entities:  

Mesh:

Year:  1985        PMID: 2984900     DOI: 10.3109/02841868509134359

Source DB:  PubMed          Journal:  Acta Radiol Oncol        ISSN: 0349-652X


  4 in total

Review 1.  Effects of cancer and anti-neoplastic treatment on the human testicular function.

Authors:  A De Palma; E Vicari; I Palermo; R D'Agata; A E Calogero
Journal:  J Endocrinol Invest       Date:  2000-11       Impact factor: 4.256

2.  Metastatic testicular cancer and extragonadal germ cell tumor presenting with neurological symptoms.

Authors:  N Borge; S D Fosså; A E Stenwig
Journal:  J Neurooncol       Date:  1990-04       Impact factor: 4.130

3.  Correlation between lectin binding and clinical factors in seminoma patients.

Authors:  R Malmi; P L Kellokumpu-Lehtinen; K O Söderström
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

4.  Years of potential life lost: evaluating premature cancer death in men.

Authors:  P C Friman; J W Finney; J M Leibowitz
Journal:  J Community Health       Date:  1989
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.